1. Zhang, Zuojing, Wang, Wei, Zhang, Yuxin, You, Xingji, Wu, Jingxiang. 2023. A potential link between aberrant expression of ECRG4 and atrial fibrillation. In Frontiers in oncology, 13, 1031128. doi:10.3389/fonc.2023.1031128. https://pubmed.ncbi.nlm.nih.gov/36910669/
2. Shaterian, Ashkaun, Kao, Steven, Chen, Lin, Eliceiri, Brian P, Baird, Andrew. 2012. The candidate tumor suppressor gene Ecrg4 as a wound terminating factor in cutaneous injury. In Archives of dermatological research, 305, 141-9. doi:10.1007/s00403-012-1276-7. https://pubmed.ncbi.nlm.nih.gov/22899245/
3. Li, Ximei, Hu, Shengjuan, Ma, Meijuan, Gao, Hengjun, Bai, Feihu. . Esophageal cancer-related gene 4 inhibits gastric cancer growth and metastasis by upregulating Krüppel-like factor 2 expression. In Annals of translational medicine, 11, 176. doi:10.21037/atm-23-139. https://pubmed.ncbi.nlm.nih.gov/36923086/
4. Cabuzu, Daniela, Ramakrishnan, Suresh K, Moor, Matthias B, Durussel, Fanny, Bonny, Olivier. 2022. Loss of Ecrg4 improves calcium oxalate nephropathy. In PloS one, 17, e0275972. doi:10.1371/journal.pone.0275972. https://pubmed.ncbi.nlm.nih.gov/36227903/